UnitedHealth
$335.679876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$335.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.02 (+0.30%) As of 8:28 PM UTC today
Why Robinhood?
You can buy or sell UnitedHealth and other stocks, options, and ETFs commission-free!
About UNH
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health services business serving the broad health care marketplace, including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the health care industry. The OptumRx segment provides pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN. The listed name for UNH is UNITEDHEALTH GROUP INCORPORATED (Delaware).
CEO
Sir Andrew Philip Witty
Employees
325,000
Headquarters
Minnetonka, Minnesota
Founded
1977
Market Cap
317.78B
Price-Earnings Ratio
20.73
Dividend Yield
1.45
Average Volume
3.61M
High Today
$337.67
Low Today
$333.90
Open Price
$335.50
Volume
1.66M
52 Week High
$367.95
52 Week Low
$187.72
UNH News
Analyst Ratings
76%
of 25 ratings
Buy
76%
Hold
24%
Sell
0%
UNH Earnings
$0.00
$2.37
$4.75
$7.12
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 14, Pre-Market